摘要
目的:观察沙培林雾化吸入联合NP方案治疗晚期非小细胞肺癌的临床疗效及其对T细胞亚群的影响。方法:选取本院收治的晚期非小细胞肺癌患者68例,随机分为沙培林雾化吸入联合NP方案组(O-NP组)及单纯NP方案组(NP组),每组各34例,比较两组治疗后的临床疗效及T细胞亚群水平。结果:O-NP组的临床疗效明显优于NP组,两组比较差异有统计学意义(P<0.05);O-NP组治疗后T细胞亚群水平明显优于治疗前,也明显优于NP组,差异均有统计学意义(P<0.05)。结论:沙培林雾化吸入联合NP方案治疗晚期非小细胞肺癌的疗效显著,可有效改善患者免疫功能,值得临床推广应用。
Objective: To observe the clinical effect of Sapylin inhalation combined with NP regimen for the treatment of advanced non-small cell lung cancer and its effects on the T lymphocyte subsets.Method : 68 cases of advanced non-small cell lung cancer in our hospital were selected, they were randomly divided into inhalation combined with NP regimen group ( O-NP group ) and NP regimen alone group ( NP group ), 34 cases in each group. The clinical efficacy of the two groups after treatment and the level of T cells subsets before and after treatment were compared.Result: The clinical effect of O-NP group was significantly better than that of NP group, the difference was statistically significant ( P〈0.05 ) .In O-NP group, the T cells subgroup level after treatment was significantly better than before, and it was also significantly better than that in NP group, the differences were statistically significant ( P〈0.05 ) . Conclusion: Sapylin inhalation combined with NP regimen for the treatment of advanced non-small cell lung cancer is effective, can effectively improve the immune function, it is worthy of clinical application.
出处
《中国医学创新》
CAS
2015年第28期38-40,共3页
Medical Innovation of China